BioSpace News Archive

Physician’s Seal, LLC, today announced that Primary Care Companion for CNS Disorders, a peer-reviewed primary care medical journal, has published results of a U.S.-based randomized, crossover pharmacokinetic (PK) evaluation study in healthy, non-smoking adults, called REMAKT (REM Absorption Kinetics Trial),

The intraoperative neuromonitoring market in the US is expected to post a CAGR of over 10% during the period 2019-2023, according to the latest market research report by Technavio.

Correvio Pharma Corp. (Nasdaq: CORV) (TSX: CORV), a specialty pharmaceutical company focused on commercializing hospital drugs, today announced the size and pricing of its previously announced underwritten public offering (the “Offering”) of 8,000,000 common shares from treasury at a price to the public of US$1.50 per common share,

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a research and development-focused biotechnology company dedicated to creating small molecule drugs for viral infections and liver diseases, today announced that the European Commission has granted marketing authorization to AbbVie for MAVIRET™ (glecaprevir/pibrentasvir) to shorten once-daily treatment duration from 12 to 8 weeks in treatment-naïve, compensated cirrhotic, chronic hepatitis C (HCV) patients with genotype (GT)1, 2, 4, 5, or 6 infection

Essenlix Corporation, a premier provider of instant personal mobile health test solutions and a global leader in the application of nanotechnology, machine learning and advanced biology for health test, announced today the development of the world’s smallest, simplest, and lowest-cost blood count device – iMOST-CBC (instant mobile self-test for complete blood count)

Navitus Health Solutions announced today the retirement of its long-time President and CEO, Terry Seligman, R.Ph., effective this week. Initially he planned to retire at the end of the year; however health issues have accelerated his retirement plans

Life Spine, a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spinal disorders, announced today that their foot and ankle division, Centric Medical, has initiated a TARSA-LINK Stand-Alone Wedge Fixation System Clinical Study with Dr. Christopher Nicholas of Norfolk Foot and Ankle in Norfolk, VA.

Onco360®, the nation’s largest independent Oncology Pharmacy, announced today that it was selected to be a specialty pharmacy network partner for Karyopharm’s new product Nubeqa® (darolutamide) for the treatment of patients with non-metastatic castration-resistant prostate cancer (nmCRPC).

TerrAscend Corp. (CSE: TER; OTCQX: TRSSF) (“TerrAscend” or “the Company”), the first and only global cannabis company licensed for sales in Canada, the US, and the EU, today announced the signing of a definitive agreement to acquire Ilera Healthcare

One of the most dangerous risks expectant mothers face as their delivery date approaches is a surprisingly common condition with a little-known name: placental accreta.